hal-allergy-group

Médias

HAL Allergy Completes Patient Enrollment for its Phase II Trial With SUBLIVAC® FIX Phleum Pratense

Médias

HAL Allergy Completes Patient Enrolment for its Phase II Trial with SUBLIVAC® FIX Birch

Médias

HAL Allergy Introduces Scientific Advisory Board

Médias

HAL Allergy Extends GMP Contract Manufacturing Activities